although there was a trend for the lytic state to be more profound in the apsac-treated patients , there was no difference between treatment groups with regard to bleeding complications or therapeutic efficacy , the latter being 79 and 73 % , respectively , for apsac and streptokinase .
C0078956
apsac
C0038418
streptokinase